AI assistant
CARDINAL HEALTH INC — Director's Dealing 2017
May 15, 2017
30089_dirs_2017-05-15_6d1c049e-8ee7-4209-96c1-7a07cec24834.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CARDINAL HEALTH INC (CAH)
CIK: 0000721371
Period of Report: 2017-05-12
Reporting Person: Giacomin Jon L (CEO, Pharmaceutical Segment)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-12 | Common Shares | M | 23270 | $41.60 | Acquired | 55440 | Direct |
| 2017-05-12 | Common Shares | S | 23270 | $72.87 | Disposed | 32170 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-12 | Employee Stock Option (right to buy) | $41.6 | M | 23270 | Disposed | 2021-08-15 | Common Shares (23270.0) | Direct |
Footnotes
F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.81 to $72.91, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.
F2: The option, representing a right to purchase a total of 23,270 shares, vested and became exercisable in three equal annual installments beginning on August 15, 2012.